0 antall prosjekter

Utvalg basert på fritekstsøk avspeiler ikke Forskningsrådets egen statistikk. Les mer...

Treff i fritekstsøk gir deg en oversikt over alle prosjekter der den aktuelle teksten ligger i prosjekttittel eller prosjektsammendrag. Det vil kunne gi et annet utvalg prosjekter enn det Forskningsrådet bruker i egen statistikk slik den fremstilles i for eksempel publikasjonene Forskningsrådet i tall eller Årsrapporten. Forskningsrådets statistikk bygger normalt på utplukk basert på faste kategorier. Disse finner du i venstremenyen, over diagrammet eller i søkefeltets venstre kolonne (statistikksøk).

Les mer...

Relevanse

CL1-Health

AI-BASED PERSONALISED CARE FOR RESPIRATORY DISEASE USING MULTI-MODAL DATA IN PATIENT STRATIFICATION

Tildelt: kr 2,0 mill.

Prosjektperiode: 2024-2027

Sted: Oslo

CL1-Health

MULti-Tumour based prediction and manipulation of Immune Response

Tildelt: kr 2,4 mill.

Prosjektperiode: 2024-2027

Sted: Oslo

CL1-Health

COordination MEchanism for Cohorts and Trials

Tildelt: kr 11,6 mill.

Prosjektperiode: 2023-2026

Sted: Oslo

MSCA-Marie Sklodowska-Curie Actions (MSCA)

Myopia - from genes and environment to cellular responses and treatment

In modern industrial societies, myopia has become an important ocular health problem of young people, due to its increased incidence and associated complications, which pose a significant risk of blindness already in the middle life span. Current treatment options have limited effects with a maxi...

Tildelt: kr 6,0 mill.

Prosjektperiode: 2023-2027

Sted: Oslo og 2 andre

CL1-Health

Enabling environments for NCD risk reduction in Ethiopia

To improve the health outcomes of its citizens, Ethiopia must take steps to meet SDG3.4 and decrease the number of premature deaths caused by non-communicable diseases (NCDs). NCD deaths are preventable by tackling their risk factors: unhealthy diets, physical inactivity, and air pollution. These...

Tildelt: kr 11,4 mill.

Prosjektperiode: 2023-2027

Sted: Oslo

CL1-Health

HARMONISED APPROACH TO EARLY FEASIBILITY STUDIES FOR MEDICAL DEVICES IN THE EUROPEAN UNION

Tildelt: kr 11,0 mill.

Prosjektperiode: 2023-2027

Sted: Oslo

ERC-European Research Council (ERC)

Untangling the biologic and social causes of low fertility in modern societies

Tildelt: kr 58,4 mill.

Prosjektperiode: 2023-2029

Sted: Oslo

CL1-Health

Burden of disease based methods for estimating the socio-economic cost of environmental stressors

Tildelt: kr 4,7 mill.

Prosjektperiode: 2023-2026

Sted: Oslo og 2 andre

CL1-Health

Running in the FAMILY - Understanding and predicting the intergenerational transmission of mental illness

Tildelt: kr 3,7 mill.

Prosjektperiode: 2022-2027

Sted: Oslo

INFRA-Research infrastructures

Environmental Exposure Assessment Research Infrastructure Preparatory Phase Project

Tildelt: kr 0,60 mill.

Prosjektperiode: 2022-2025

Sted: Oslo

CL1-Health

A clinical research network to improve the management of Monkeypox virus disease

Tildelt: kr 6,6 mill.

Prosjektperiode: 2022-2026

Sted: Oslo

CL1-Health

Building a European strategic Research and Innovation Area in Direct Synergy with EU and International Initiatives for Pandemic Preparedness

Tildelt: kr 0,70 mill.

Prosjektperiode: 2022-2025

Sted: Oslo

CL1-Health

Partnership for the Assessment of Risks from Chemicals

Tildelt: kr 79,8 mill.

Prosjektperiode: 2022-2029

Sted: Oslo og 5 andre

CL1-Health

ENDING COVID 19 VARIANTS OF CONCERN THROUGH COHORT STUDIES: END-VOC

The END-VOC consortium will support the European and global response to the COVID-19 pandemic and Variants of Concern (VOC) through well characterised cohorts and linked with existing European and international initiatives. END-VOC consists of 19 partners in Europe (UK, Spain, Italy, Germany, Net...

Tildelt: kr 0,89 mill.

Prosjektperiode: 2022-2025

Sted: Oslo

CL1-Health

European Clinical Research Alliance on Infectious Diseases - PRIMary care adaptive platform trial for pandemics and Epidemics

European citizens affected by COVID-19 have been well-served by landmark clinical trials in hospitals that have found treatments that save many lives. However, there are fewer opportunities for people in the community to contribute to the urgent mission of finding treatments that speed recovery, ...

Tildelt: kr 1,4 mill.

Prosjektperiode: 2021-2024

Sted: Oslo

H20-TPT-Smart, green and integrated transport

ULtrafine particles from TRansportation – Health Assessment of Sources

Current legislative control of particulate matter (PM) based on ambient mass concentrations does not encompass source dependent variation in PM toxicity or the impact of high numbers of nanoparticles (ultrafine particles; UFPs) which contribute little to PM mass. UFPs may pose high risks due to t...

Tildelt: kr 8,2 mill.

Prosjektperiode: 2021-2025

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Ontology-driven and artificial intelligence-based repeated dose toxicity testing of chemicals for next generation risk assessment

The vision of the ONTOX consortium is to provide a functional and sustainable solution for advancing human risk assessment of chemicals without the use of animals in line with the principles of 21st century toxicity testing and next generation risk assessment. Specifically, ONTOX will deliver a g...

Tildelt: kr 12,4 mill.

Prosjektperiode: 2021-2026

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

POLYRISK - Understanding human exposure and health hazard of micro- and nanoplastic contaminants in our environment

Tildelt: kr 9,2 mill.

Prosjektperiode: 2021-2025

Sted: Oslo

H20-ERC-European Research Council

Understanding the causal nature of the relationship between infertility and cardiovascular disease

Tildelt: kr 15,9 mill.

Prosjektperiode: 2021-2025

Sted: Oslo

H20-INFRA-Research infrastructures

Population Health Information Research Infrastructure

A structured European mechanism for COVID-19 exchange to organize and share information between countries is urgently needed, especially in the area of population health. Information on the broader impacts of COVID-19 on the health of populations is needed to facilitate multidisciplinary European...

Tildelt: kr 0,53 mill.

Prosjektperiode: 2020-2023

Sted: Oslo

H20-ENV-Climate action, environment, resource efficiency and raw materials

Enhancing Belmont Research Action to support EU policy making on climate change and health

Tildelt: kr 9,0 mill.

Prosjektperiode: 2020-2023

Sted: Oslo

H20-EURATOM-EURATOM

Towards effective radiation protection based on improved scientific evidence and social considerations - focus on radon and NORM

RadoNorm is designed to initiate and perform research and technical development in support of European Union Member States, Associated Countries and the European Commission in their efforts to implement the European radiation protection Basic Safety Standards. The proposed multidisciplinary and i...

Tildelt: Skjult

Prosjektperiode: 2020-2025

Sted: Oslo og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

European Research and Preparedness Network for Pandemics and Emerging Infectious Diseases

The overall objective of this 5-year project is to build a multinational, adaptive European COVID-19 and emerging infectious diseases trial network, based on existing initiatives, experience and expertise, allowing European expansion of DisCoVeRy (WP1) and the establishment of a COVID19 adaptive ...

Tildelt: kr 11,5 mill.

Prosjektperiode: 2020-2025

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Rapid European SARS-CoV-2 Emergency research Response

RECoVER (Rapid European SARS-CoV-2 Emergency Research response) is a comprehensive research response to the SARS-CoV-2 outbreak addressing the most urgent questions for patient and public health level interventions. RECoVER originates from partners of the EU Framework 7 (FP7) funded PREPARE proje...

Tildelt: kr 0,67 mill.

Prosjektperiode: 2020-2022

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome

Immune-mediated, non-communicable diseases, such as autoimmune diseases, allergic diseases and asthma, are chronic disorders in which the interaction between exposome and immune system plays a pivotal role. As prevalence and societal costs of these diseases are rising in the EU, a holistic approa...

Tildelt: kr 13,2 mill.

Prosjektperiode: 2020-2024

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Human Exposomic Determinants of Immune Mediated Diseases

Tildelt: kr 6,3 mill.

Prosjektperiode: 2020-2024

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Molecular Mechanisms Associating Chronic Pain with Fatigue, Affective Disorders, Cardiovascular Disease and Total Comorbidity

Chronic pain (CP) is the leading cause of disability, and is strongly associated with fatigue, anxiety and depression also major contributors to disability, and with cardiovascular disease (CVD) and mortality. Twin studies indicate that these associations are a consequence of common causal mecha...

Tildelt: kr 21,2 mill.

Prosjektperiode: 2020-2024

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Advancing Tools for Human Early Lifecourse Exposome Research and Translation

Tildelt: kr 20,6 mill.

Prosjektperiode: 2020-2024

Sted: Oslo

H20-ENV-Climate action, environment, resource efficiency and raw materials

Exposure to heat and air pollution in EUrope – cardiopulmonary impacts and benefits of mitigation and adaptation

Tildelt: kr 25,9 mill.

Prosjektperiode: 2019-2023

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Scaling up the WHO-PEN package for diabetes and hypertension in Swaziland: a nation-wide cluster-randomised evaluation of three strategies in Swaziland (WHO-PEN@Scale)

Swaziland has a very high prevalence of both diabetes and hypertension, with the majority of those affected being undiagnosed. Like many other countries in sub-Saharan Africa (SSA), however, Swaziland provides care for diabetes and hypertension only through physician-led teams in hospitals. The c...

Tildelt: kr 2,1 mill.

Prosjektperiode: 2019-2023

Sted: Oslo

1 2 3